BioHarvest Sciences Inc. maintains its annual revenue guidance range at $42M to $48M, reflecting the company's outlook for the upcoming fiscal year.
Bullish
BioHarvest Sciences Inc. saw 8% revenue growth and improved gross margins, with CDMO revenue up 135% from project milestones. The VINIA brand became the number one resveratrol polyphenol brand in the USA.
Bearish
BioHarvest Sciences Inc. experienced increased operating and net losses in Q1 2026, due to higher expenses. The company also faces long lead times for new manufacturing and risks with future CDMO contracts and commercialization.